New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 10, 2014
05:53 EDTALXNAlexion price target raised to $205 from $125 at Deutsche Bank
Deutsche Bank raised its price target for shares of Alexion Pharmaceuticals to $205 citing upside potential from the company's launch of Asfotase Alfa for severe Hypophosphatasia. The firm keeps a Buy rating on the stock.
News For ALXN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for ALXN

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use